Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q14028: Variant p.Arg762Cys

Cyclic nucleotide-gated channel beta-1
Gene: CNGB1
Feedback?
Variant information Variant position: help 762 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Cysteine (C) at position 762 (R762C, p.Arg762Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In RP45; likely pathogenic. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 762 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1251 The length of the canonical sequence.
Location on the sequence: help LLSLLPLDFLYLKVGVNPLL R LPRCLKYMAFFEFNSRLESI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         LLSLLPLDFLYLKVGVNPLLRLPRCLKYMAFFEFNSRLESI

Mouse                         LLCLLPLDFLYLKLGINPLLRLPRCLKYMAFFEFNNRLEAI

Rat                           LLCLLPLDFLYLKLGVNPLLRLPRCLKYMAFFEFNNRLEAI

Bovine                        MLCLLPLDLLYLKFGVNPLLRLPRCLKYMAFFEFNNRLESI
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1251 Cyclic nucleotide-gated channel beta-1
Transmembrane 761 – 773 Helical; Name=S4
Alternative sequence 300 – 1251 Missing. In isoform GARP2.
Helix 759 – 767



Literature citations
Homozygosity mapping in autosomal recessive retinitis pigmentosa families detects novel mutations.
Bocquet B.; Marzouka N.A.; Hebrard M.; Manes G.; Senechal A.; Meunier I.; Hamel C.P.;
Mol. Vis. 19:2487-2500(2013)
Cited for: INVOLVEMENT IN RP45; VARIANT RP45 CYS-762; Olfactory Dysfunction in Patients With CNGB1-Associated Retinitis Pigmentosa.
Charbel Issa P.; Reuter P.; Kuehlewein L.; Birtel J.; Gliem M.; Tropitzsch A.; Whitcroft K.L.; Bolz H.J.; Ishihara K.; MacLaren R.E.; Downes S.M.; Oishi A.; Zrenner E.; Kohl S.; Hummel T.;
JAMA Ophthalmol. 136:761-769(2018)
Cited for: INVOLVEMENT IN RP45; VARIANTS RP45 438-GLN--GLU-1251 DEL; HIS-737; CYS-762; 921-TYR--GLU-1251 DEL AND ILE-986;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.